| Reduced Risk Status: |
THIS AI HAS BEEN CLASSIFIED AS RR FOR ONE OR MORE FOOD USES.
|
| IPM Compatibility: |
|
| Reasons for need: |
|
| Requesting State(s): |
HQ:Braverman, M* ;
|
| PCR Use Pattern: |
USE THE AVAUNT 30% WG (30% AI) PRODUCT; MAKE 4 FOLIAR APPLIC OF 0.1125 LB AI/A IN 50-200 GPA, 7-DAY INTERVALS, 14-DAY PHI; INCLUDE AN ADJUVANT AT A LABELED RATE UNLESS ABSENCE OF AN ADJUVANT IS BEING USED TO DIFFERENTIATE MORE THAN ONE TRIAL BY THE SAME RESEARCHER
|
| EPA Default Residue Trials: |
13-5
|
| IR-4 Residue Trial Plan: |
13-5
|
| Residue Protocol Use Pattern: |
|
| Efficacy/Crop Safety (E/CS) Data Required: |
|
| E/CS Research Comments: |
|
| Label Use Pattern Submitted To EPA: |
|
| EPA PIF Status: |
|
| EPA Status: |
|
| EPA PRIA Date: |
|
| MRID: |
|
| Comments: |
US STUDY FOR THIS IS UNDER PR# 11467. INTERNATIONAL PROTOCOL FOR DEVELOPING DATA IN UGANDA, PR# 13212, AND COSTA RICA, PR# 13221 (This PR#) TO DEVELOP CODEX MRL. TO BE FUNDED THROUGH THE MINOR USE FOUNDATION. RESIDUE DECLINE STUDY TO BE CONDUCTED IN UGANDA. (JB):04/21;
|
| International Status: |
|
| Archive Location: |
|
| QA Archive: |
|